Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory

Red Light Holland is continuing its groundbreaking working synergies with Shaman Pharma Corp. and their cGMP laboratory partner, CCrest Laboratories Inc. who holds a Controlled Drugs and Substances License issued by Health Canada
Red Light Holland previously completed two exports, under Health Canada psilocybin import permits, for commercial sale of psilocybe truffles grown in the Company’s farm in Horst, Netherlands to CCrest Laboratories’ cGMP pharmaceutical laboratory in Montreal, Canada
Red Light Holland’s psilocybe truffles are being evaluated and tested by CCrest Laboratories for:
- The suitability of Red Light Holland’s naturally occuring psilocybin as a source of active pharmaceutical ingredients (“API”) for scientific and potentially medical and therapeutic purposes
- Providing Red Light Holland customers with scientific information regarding relative strength of different truffles strain sold
- Moving towards dose standardization in anticipation of Oregon measure 109 and potentially other world wide locations.
Red Light Holland and CCrest Laboratories continue to demonstrate their strong commitment to the highest regulatory compliance standards

Toronto, Ontario–(Newsfile Corp. – November 15, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles, is pleased to announce that it has received the first reports, produced by Shaman Pharma Corp. and CCrest Laboratories Inc. under Health Canada approval, evaluating the suitability of Red Light Holland’s natural psilocybin as a source of active pharmaceutical ingredients (“API”) for scientific and potentially medical and therapeutic purposes.

“This report is a step forward both for the recreational market, as well as the pharmaceutical market interested in naturally occurring psilocybin. We’re excited to share some of the scientific findings from the report on the three different truffles strains that we grow in The Netherlands, for our newly launched variety of products such as the iMicrodose Triniti pack, featuring all three strains that were tested,” said Todd Shapiro, CEO and Director of Red Light Holland. “Red Light Holland and Shaman Pharma are once again pushing the limits, having a true ally and partner with cutting-edge scientific expertise to evaluate our truffles. This is certainly a major milestone in Red Light Holland’s mandate of pursuing research and development, product advancements, technology and applied science which bolsters our Scarlette Lillie Science and Innovation division.”

Red Light Holland initially supplied its truffles in March 2021, with a second shipment in August 2021, to CCrest Laboratories, a cGMP pharmaceutical laboratory in Montreal enabled with a Health Canada Controlled Drugs and Substances license, specializing in highly regulated narcotics, including psychedelics. The raw materials proved to be suitable to complete the first phase of the scientific research, which included the development of proprietary analytical methods and protocols, such as assays to determine the presence and concentration of psilocybin and performing extraction to isolate psilocybin, from both fresh and dried sclerotia.

These cGMP compliant scientific methods and protocols of Quality Control, Analysis and Extraction are aimed at developing intellectual property for achieving the industrial-scale commercialization of medical purpose psychedelic substances in this emerging pharmaceutical sector. Exceeding the exacting regulatory requirements opens a new realm of possibilities for disruptive healthcare innovation using natural psychedelic mushroom derivatives.

Given the prohibited status of psilocybin, listed along Schedule I drugs under the United Nations 1971 Convention on Psychotropic Substances, science on the subject has remained limited, mostly manifested in the literature and methods produced in academic settings. Some of the known compounds in magic mushrooms – psilocybin, psilocin, norpsilocin, baeocystin, norbaeocystin, and aeruginascin – present similarities in their molecular structure, yet these chemicals can react with significant variation in the laboratory, and their little-known differences in behavior once inside the body could prove complimentary or synergistic, possibly creating a so-called entourage effect.

The report demonstrates that different solvents, such as water and methanol in various ratios, render extraction at different speed and quantity and can transform the compounds in the process. Using the same materials with various process modifications, the individual effect on an organism (e.g., human) could yield a significant difference in cognitive experience. In human metabolism, psilocybin is primarily a pro-drug that is dephosphorylated to active metabolite psilocin. One variation in the extraction method has yielded exclusively psilocin, indicating it could bypass dephosphorylation in the metabolism. These variations can lead to discovering innovative delivery mechanisms, which could provide better control between the onset speed and effective duration.

As one of the involved scientists explains, they have positively answered the hypothesis “what if?…” Red Light’s truffles are a viable source of active compounds, the next objective is using the compounds in the development process of pharma-grade ingredients or creating standardised doses for legal markets. With the first phase considered a success, the companies are wrapping up this work and moving to the next phases.

The scientists are now focusing on optimizing the extraction yield, as well as generating comparative data between the raw material attributes: genetic, size and weight, water content, and so on, as factors that can establish the proportions and total content of the various compounds, in a newly developed proprietary protocol identified as SP1-173-L – Qualitative and Quantitative Determination of Psilocybin & Psilocin truffles and mushrooms by Liquid Chromatography.

The objective of the SP1-173-L protocol is to assess the content of compounds in three species of truffles: Galindoi, Mexicana & Tampanensis, using the Liquid Chromatography method developed at CCrest Laboratories. The study will address the suitability of the analytical procedure, the assay of compounds in the three varieties of truffles and the variability of contents within the species and truffles size. Water content will be determined for all specified and sized samples. The tests will be performed by trained analysts at CCrest Laboratories, ensuring that the facilities and instrumentation are properly calibrated and qualified as needed. The laboratory systems will be in compliance with applicable regulations and in-house general laboratory procedures.

This protocol defines the experimental design and the data to be collected for the comparison of compounds contained in truffles of different size and species. The assay is conducted on three species of truffles, supplied by Red Light Farm. The data evaluation consists of:

Evaluation of the suitability of the analytical procedure SP1-173-L (precision and repeatability of injection).
The comparison of content of compounds will be obtained from three different samples from each species: small truffles, big truffles and a mix of small and big truffles, for a total of nine samples.
Determination of water content in the three different species of fresh truffles: Galindoi, Mexicana and Tampanensis.

In previous assays detailed in the reports, the Mexicana species appeared to be the most potent by a few percentage points, measuring at just under 1mg/gram of combined psilocybin and psilocin. The Tampanensis showed the highest proportion of psilocybin, the psilocin composing less than 10% of the total. The Galindoi, while the least potent overall, demonstrated the most balanced mix, with the psilocin equal to slightly more than 50% of the psilocybin content. While these three species are currently sold legally in the Netherlands, due to regulatory restrictions it has not been possible before now to achieve this level of comparison in a formal cGMP setting.

“We are advancing in uncharted territory where we are discovering a promising horizon, so we are definitely motivated to keep moving forward. This scientific work barely scratches the surface of possibilities, we are excited to increasingly deploy our proven pharma abilities in deepening the qualification of Red Light Holland`s truffles as a source of novel therapeutic ingredients,” commented Alex Grenier, CEO of Shaman Pharma and President of CCrest Laboratories. “While synthetic psychedelics are dominating the field, it makes sense to look at the original natural source, because something like an entourage effect would not be reproduced by synthesis. Just as much-hyped artificial cannabinoid analogues were not successful in displacing phytocannabinoids (marijuana), we anticipate the development of a tremendous share of demand for natural psychedelic mushroom derivatives, initially to supply research before cascading downstream to larger markets. Our approach, which is scientific, rigorous, and calculated, is also tailored to the real-world movement out there, the active audience for psychedelics, including many scientists, who are demanding natural origins.”

Red Light Holland continues to establish itself as a leader in the recreational sector and push for legal, responsible and safe access to natural psychedelic truffles/mushrooms while Scarlette Lillie Science and Innovation pursues research and development, technology, and applied science.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles.

For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

Forward-Looking Statements

About Shaman Pharma Corp.

Shaman Pharma is a federally registered Canadian corporation with the mission to power outstanding psychedelic life science innovation. Accelerating time-to-market through its portfolio of assets, Shaman launches and consolidates revenue-driven pharma-biotech life sciences ventures focused on supplying psychedelic drugs & novel active ingredients.

Forward-Looking Statements

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the control of Red Light Holland. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward looking statements include, but are not limited to: statements with respect to the evaluation and testing of the Company’s naturally occurring psilocybe truffles by CCrest Laboratories for scientific and medical purposes; the potential of the Company’s products being used for scientific and medical purposes; statements with respect to the Company’s expansion into the mental wellness pharmaceutical sector; the future sharing of the test results with the Company’s customers and shareholders; and the Company’s ability to establish itself as the leader in the recreational psychedelics sector.

Forward-looking information is based on a number of key expectations and assumptions made by Red Light Holland, including without limitation: the COVID-19 pandemic impact on the Canadian economy and Red Light Holland’s business, and the extent and duration of such impact; no change to laws or regulations that negatively affect Red Light Holland’s business; there will be a demand for Red Light Holland’s products in the future; no unanticipated expenses or costs arise; the Company will be able to continue to develop products that are allowed to be imported and sold under Health Canada’s import permit; and the partnership with Shaman Pharma Corp. will help Red Light Holland to achieve its business goals. Although the forward-looking information contained in this news release is based upon what the Company believes to be reasonable assumptions, it cannot assure investors that actual results will be consistent with such information.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the inability of the Company to continue as a going concern; the inability of the Company to obtain all necessary governmental and/or other regulatory approvals, licenses, and permits necessary to operate and expand the Company’s facilities; the effect of regulatory and/or political change and its effect on the legislation and regulations surrounding the psychedelics industry; p negative perception of the medical-use and adult-use psilocybin industry; the inability of CCrest to complete the planned testing of the Company’s products; the potential unviability of psilocybin for medical and/or scientific purposes; the inability of the Company to continue its growth; the Company’s limited operating history; reliance on management; the Company’s requirements for additional financing; and competition for mental health and wellness investments.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

November 2, 2021March 10, 2022

Complete Results from Red Light Oregon Market Research in Oregon Show Microdosing Services Market Size per Annum Estimated at a Billion USD

Toronto, Ontario–(Newsfile Corp. – November 2, 2021) – Red Light Oregon, Inc. (“Red Light Oregon“) a 50/50 joint venture of Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9KN) (“Halo Collective“) and Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland“), is pleased to announce the release of its findings from a statistically significant and representative market study of Oregon adults. The market research study (the “Market Research Study“), aimed to gather insights on the likely beneficiaries of Measure 109 and the legalization of psilocybin services by the Oregon Health Authority (“Psilocybin Services“) for adults in Oregon and help support the Oregon Psilocybin Advisory Board (OPAB) and health officials in making data-informed regulations.

The market research utilized an online survey with 13 questions answered by 473 Oregonians. The survey was powered by Dynata Insights Platform to ensure accurate quota sampling. The data was analyzed by data scientist Alicia Chen.
In addition, to the market research, a literature review was conducted by Dr. Rohit Singh, A Ph.D. Organic Chemist and a Research Assistant Professor in the Center for Drug Design – the University of Minnesota, to assess the safety of long term activation of 5ht2b receptors by microdosing of psilocybin.

The Market Research Study has uncovered:

At least 16% of adults in Oregon are interested in Microdosing services on a weekly basis or more.
47% of those interested in Microdosing were interested in “Microdosing in a Mindfulness workshop”.
The preferred price for Microdosing services such as microdosing and mindfulness workshops, microdosing and creativity workshops, or dedicated microdosing co-working spaces is on average above $50 USD.
When combining this information with the adult (21+) population size of Oregon being 2,429,348 we get a calculation of 2,429,348 X 16%(adults interested in microdosing weekly) X 50 USD (preferred price) X 52 (weeks a year) equal to 1,010,608,768 per annum estimated market size.

Based on this data, Red Light Oregon will be reaching out to OPAB members to offer recommendations found in the report, available at www.RedLightOregon.com, including:

Allowing more clients per facilitator in a group session when using low doses of psilocybin as a safe way to lower the price of psilocybin services.
Lower doses should be clarified in regulations to be no more than 3 mg of psilocybin.
Lower dose session time should be clarified to be shorter than a full dose session.
One intake session should be clarified to be enough for 6 months of lower dose service received up to 5 times a week.
Tiered prices for lower-income clients should be encouraged.
Including an internship component in facilitator training may decrease the prices of group sessions also for high dose services.

Red Light Holland plans to conduct research in the Netherlands, where psilocybin is legal, to understand the optimal ratio for facilitators in a group setting with a dose of up to 3 mg of psilocybin per person as well as the optimal time for these low dose sessions.

“The data shows a very big interest in Microdosing services on a regular basis,” said Todd Shapiro, CEO, and Director of Red Light Holland. “Measure 109 is focused on equity, and microdosing is a great way to bring psilocybin services to lower-income clients. The Microdosing and Mindfulness and Microdosing and creativity workshops we have been running in the Netherlands seem to have a great interest for the people of Oregon.”

“We are seeing that Microdosing services have the potential of being as large of a market as cannabis. We believe there is a huge opportunity for a company with our shared expertise to provide the people of Oregon with the best services,” added Katie Field, Co-President of Red Light Oregon and President and Executive Director at Halo Collective.

“With so many people interested in microdosing on a regular basis, it was imperative for us to conduct a literature review regarding the long-term safety of microdosing activation of the 5ht2b receptor that has been implicated in health issues. While we can not give medical advice, we are very happy to provide the information we collected from existing literature on what is considered a safe recurring microdosing dose to OPAB. Katie Fields and I plan on using our collective networks to reach out to members of OPAB, in hopes of discussing these very thorough findings to increase equity and accessibility,” said Sarah Hashkes, Co-president of Red Light Oregon and Chief Technology and Innovation Officer of Red Light Holland.

The full report can be found on Red Light Oregon Website www.RedLightOregon.com

Measure 109 will make Psilocybin Services available to 21 years and older in Oregon who think they can benefit from them without a need for medical diagnosis. The service must include a prep-session, psilocybin session in a licensed facility supervised by a licensed facilitator and a possibility of an integration session. On December 31, 2022, the Oregon Health Authority will prescribe forms and regulations necessary for the exact implementation.

Below are some of the answers from the 42% of adults in the sample from Oregon interested in paying for Microdosing Psilocybin Services.

Figure 1

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/101693_f6c166e88441183c_001full.jpg

Figure 2

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/101693_f6c166e88441183c_002full.jpg

Figure 3

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/101693_f6c166e88441183c_003full.jpg

About Red Light Oregon

Red Light Oregon is an Oregon-based company that is a 50/50 joint venture between Halo Collective Inc. and Red Light Holland Corp. Red Light Oregon is developing a commercialization strategy for Psilocybin Services in Oregon utilizing a holistic approach based on the latest neuroscience research and in accordance with Measure 109, which is a measure aimed at legalizing Psilocybin Services. In addition, Red Light Oregon focuses on increasing accessibility and equity to Psilocybin Services in Oregon by promoting education, research, and accessible pricing.

About Halo Collective Inc.

Halo Collective is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures, and distributes quality cannabis flower, oils, and concentrates and has sold approximately eleven million grams of oils and concentrates since inception. The company continues to expand its business and scale efficiently, partnering with trustworthy leaders in the industry who value Halo Collective’s operational expertise in bringing top-tier products to market.

Halo Collective currently operates in the United States in Oregon and California, Canada, Southern Africa in the Kingdom of Lesotho, and the United Kingdom. The company sells cannabis products principally to dispensaries in the U.S. under its brands Hush, Mojave, and Exhale, and under license agreements with Papa’s Herb®, DNA Genetics, Terphogz, and FlowerShop*, a cannabis lifestyle and conceptual wellness brand that includes G-Eazy as a partner and key member.

As part of continued expansion and vertical integration in the U.S., Halo Collective boasts several grow operations throughout Oregon and two planned in California. In Oregon, the company has a combined 11 acres of owned and contracted outdoor and greenhouse cultivation, including East Evans Creek, a six-acre grow site in Jackson County with four licenses owned and operated by Halo Collective and two third-party licenses under contract to sell all of their product to Halo Collective; Winberry Farms, a one-acre grow site located 30 miles outside of Eugene in Lane County with a license owned and operated by Halo Collective; and William’s Wonder Farms, a three-acre grow site in Applegate Valley, under contract to sell all of its product to Halo Collective pending the closing of Halo Collective’s acquisition of its licenses and business assets. Halo Collective has recently acquired Food Concepts LLC, a master tenant of a 55,000 sq.ft. indoor cannabis cultivation, processing, and wholesaling facility in Portland, Oregon operated by the Pistil Point entities.

In California, the company is building out Ukiah Ventures, a planned 30,000 sq. ft. indoor cannabis grow and processing facility, which will include up to an additional five acres of industrial land to expand the site. Recently, Halo Collective partnered with Green Matter Holding in California to purchase a property in Lake County, developing up to 63 acres of cultivation, comprising one of the largest licensed single site grows in California. Halo Collective also plans to expand its operations in California by opening three dispensaries in North Hollywood, Hollywood, and Westwood, one of which may serve as the first FlowerShop* branded dispensary.

In Canada, Halo Collective acquired three KushBar retail cannabis stores located in Alberta as a first in its planned entry into the Canadian market, leveraging its Oregon and California brands. With the KushBar retail stores as a foundation, the company plans to expand its foothold in Canada.

Halo Collective has also acquired a range of software development assets, including CannPOS, Cannalift, and, more recently, CannaFeels. In addition, Halo Collective owns the discrete sublingual dosing technology, Accudab. The company intends to spin-off these assets and its intellectual property and patent applications into its subsidiary Halo Tek Inc. and expects to complete a distribution to shareholders on a record date to be determined by Halo Collective.

Halo Collective has recently announced its intention to reorganize its non-U.S. operations into a newly formed entity called Akanda Corp. (“Akanda“), whose mission will be to provide high-quality and ethically sourced medical cannabis products to patients worldwide. Akanda will seek to deliver on this promise while driving positive change in wellness, empowering individuals in Lesotho, and uplifting the quality of the lives of employees and the local communities where it operates, all while limiting its carbon footprint. Akanda will combine the scaled production capabilities of Bophelo Bioscience & Wellness Pty. Ltd., Halo Collective’s Lesotho-based cultivation and processing campus located in the world’s first Special Economic Zone (SEZ) containing a cannabis cultivation operation, with distribution and route-to-market efficiency of Canmart Ltd., Halo Collective’s UK-based fully approved pharmaceutical importer, and distributor that supplies pharmacies and clinics within the U.K. With a potential maximum licensed canopy area of 200 hectares (495 acres), Bophelo has scalability that is arguably unmatched in the world today.

For further information regarding Halo Collective, see Halo Collective’s disclosure documents on SEDAR at www.sedar.com

Connect with Halo Collective: Email | Website | LinkedIn | Twitter | Instagram

About Red Light Holland Corp.

The company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information:

Todd Shapiro
Chief Executive Officer, Chairman, and Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

Forward Looking Statements

This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements.

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: Red Light’s plans to conduct research in the Netherlands, statements regarding Red Light Oregon’s community outreach and advocacy programs; the intended outcomes and effects of Measure 109; statements regarding the implementation of Measure 109 by the Oregon Health Authority; Halo Collective’s expansion and vertical integration plans, including the buildout of Ukiah Ventures; Halo Collective’s intended spin-off of the assets, intellectual property, and patent applications of Accudab into its subsidiary Halo Tek Inc.; and Halo Collective’s plans to reorganize its non-U.S. operations into a newly formed entity called Akanda.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: Red Light Holland’s ability to continue as a going concern; the continued commercial viability and growth in popularity of psilocybin products; continued approval of Red Light Holland and Halo Collective’s activities by the relevant governmental and/or regulatory authorities; and the continued growth of Red Light Holland and Halo Collective.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of Red Light Holland to continue as a going concern; the risks associated with the psychedelics industry in general; increased competition in the recreational and medical psilocybin markets; the potential future unviability of the psychedelics industry; public opinion and perception of the psychedelics industry; incorrect assessment of the value and potential benefits of expansion plans and various transactions; risks associated with potential governmental and/or regulatory action with respect to the psychedelics industry; changes in general economic, business and political conditions, including changes in the financial and stock markets; and risks related to infectious diseases, including the impacts of the COVID-19 pandemic.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect Red Light Holland’s expectations as of the date hereof and are subject to change thereafter. Red Light Holland undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

November 1, 2021March 10, 2022

Red Light Holland Appoints New Chief Financial Officer

● David Ascott has been appointed as Chief Financial Officer of Red Light Holland, a Psychedelics Company with more than $28 million of working capital*

● Bruce Linton, heavily involved in the CFO hiring process “ecstatic” to have Mr. Ascott join CEO Todd Shapiro and the Red Light Holland Team

Toronto, Ontario–(Newsfile Corp. – November 1, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce David Ascott will become Red Light Holland’s Chief Financial Officer (“CFO”) effective November 2nd, 2021. The organization’s current CFO, Kyle Appleby, will assist with a smooth transition before moving on to focus on new opportunities. CEO Todd Shapiro and the Board of Directors wish to extend their gratitude to Mr. Appleby for his efforts and leadership during an important and initial stage in Red Light Holland’s journey.

Mr. Ascott whose past includes being the CFO (2011-2018) for Rocky Mountain Dealerships Inc., an agricultural equipment company with $1B in revenue, joins Red Light Holland after most recently being a Chief Financial Officer with an early stage private cannabis producer. Mr. Ascott, a CPA with over 30 years’ experience, began his career in public practice with Ernst & Young where he progressed to Senior Manager serving a variety of clients both domestically and abroad.

“Red Light Holland continues to exhibit vision and aggressive execution,” said Bruce Linton, Red Light Holland’s Chair of the Advisory Board. “We are a psychedelics company generating revenue, who have acquired multiple companies, acted on bought deals and are evermore analyzing our next moves for growth with our advantageous cash position – which is why I’m ecstatic that David Ascott is joining the Red Light Holland team. Todd Shapiro and I interviewed numerous candidates and together we realized David’s astute financial leadership with regulations, reporting, budgeting, operations and being a part of a team that grew revenues to 1 Billion dollars with a past company – would all lend well to helping with strategic growth and compliment our careful spending habits.”

“It is exciting to be joining a pioneering company in a growth sector,” added David Ascott, incoming Red Light Holland CFO. “The Red Light Holland team has the commitment and expertise to execute its strategic initiatives for the potential of psychedelics to help with positive change and continually lead the charge on providing access. I am proud to bring my dedication and financial leadership to this organization, with its balance sheet strength, including a significant cash balance, as we focus on revenue growth & future M&A opportunities while building global supply chains, distribution networks and a world class brand.”

“This is a significant day for Red Light Holland and all of our shareholders,” said Todd Shapiro, CEO and Director of Red Light Holland. “David Ascott will immediately help us with several important growth initiatives including increasing revenue growth and potential future M&As. I’m looking forward to working very closely with David who is very committed to Red Light Holland’s mission and vision.”

In consideration for Mr Ascott’s services, on top of his salary agreement, the Company authorized the grant of 1,000,000 incentive stock options to Mr. Ascott, with each such option entitling the holder thereof to acquire one common share in the capital of the Company for a period of 3 years, at an exercise price of $0.185 per common share. The Options shall vest according to the following schedule: (a) 1/3 of the Options shall vest one (1) year following the date of issuance; and Following the first year of the Agreement, the remaining 2/3 of the Options shall begin to vest in equal increments every six (6) months, such that 166,666 Options shall vest every six (6) months.

The Company would also like to take this time to acknowledge that CEO and Director Todd Shapiro is recovering from his recent COVID-19 diagnoses. On Behalf of the Board of Directors we wish our fearless leader and his wife, 6 year old son and 2 year old daughter a speedy recovery. Unfortunately, the diagnoses of COVID-19 limited Todd’s travel to The Netherlands where he was to meet up with Russell Peters, the company’s Chief Creative Officer and document Russell’s first psychedelic experience with Red Light Holland’s therapist and expert psychedelic guide Jeff Hamburg. As a result, both Russell Peters and Todd Shapiro have postponed traveling to The Netherlands for the documentation and live-stream event which was announced on October 15th, 2021, which will be rescheduled as soon as possible.

“I’m just glad my man Todd Shapiro and his family are recovering from COVID-19,” said Russell Peters, Chief Creative Officer. “It’s no joke. Neither is opening up about mental health and I assure everybody when the time is right, Todd and I expect to get to The Netherlands, where my plan is to have a guided truffle therapy experience and open up about my journey for the world to see. I truly believe that the more of us who tackle our demons and then share those outcomes will be beneficial for people everywhere and I feel blessed to be in a position to potentially help those struggling.”

Red Light Holland and Russell Peters will share more details, about where and when people in the Netherlands can attend the live intimate event and where individuals all around the world can view the live-stream, in due course.

*Unaudited

About Red Light Holland

The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the appointment of David Ascott as it relates to the expected growth initiatives including increasing revenue growth and potential future M&As; Russell Peters’ ability to get to the Netherlands, the anticipated journey facilitated by Jeff Hamburg, the intimate live event featuring Russell Peters and the live-streaming of the event; the commencement and projected date regarding the Company’s ability to ensure the live event will happen on the Company’s social media accounts, the venue for the event; statements about the future of the live session with Russell Peters, Jeff Hamburg providing support, with respect to live journey; and expectations for other economic, business, and/or competitive factors.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, expectations regarding future growth and expansion of the operations of the business; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets; risks related to infectious diseases, including the impacts of the COVID-19 pandemic; legal and regulatory risks inherent in the psychedelics industry, including the global regulatory landscape and enforcement related to psychedelics; political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the psychedelics industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com, including the Company’s annual information form for the year ended March 31, 2020.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

October 15, 2021March 10, 2022

Red Light Holland: Global Comedy Star Russell Peters to Have a Psychedelic Journey with Red Light Holland’s Natural Psilocybin Truffles and Red Light Holland’s Therapist in Amsterdam

● Red Light Holland to live stream an intimate Russell Peters performance in front of a live audience, after he completes his journey, on multiple social media accounts

● Red Light Holland to document Russell Peters moments in The Netherlands, as he will be accompanied by a camera crew

Toronto, Ontario–(Newsfile Corp. – October 15, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce Russell Peters, the company’s Chief Creative Officer, will be in Amsterdam to experience his first psychedelic journey, in late October, 2021. Russell will be using Red Light Holland’s premium psilocybin truffles and will be guided by Red Light Holland’s therapist and expert psychedelic guide Jeff Hamburg. Peters will be accompanied by a camera crew and will give a special performance in front of a live audience which will be live-streamed on Red Light Holland social media accounts after he completes his journey and integration session. More details about the location and exact times, anticipated to happen in late October 2021, will be released next week.

“I just hope after I deal with all my trauma I still stay funny,” said Russell Peters, Red Light Holland’s Chief Creative Officer. “Seriously though, I’m truly ready for this future journey. I know I’m in the best hands with the Red Light Holland team and I hope what I learn, and ultimately share to the world, will help me and hopefully help others.”

“Russell is a great asset to Red Light Holland not only in his creativity, reach and helping plan strategy, but also in his willingness to be a role model and share his future experience in guided therapy,” said Todd Shapiro, CEO and Director of Red Light Holland. “Red Light Holland is on a mission to take magic truffles from underground to mainstream while promoting the responsible use of psychedelics as a tool for growth. Russell’s candidness about his journey will help us get this important information out to a wider audience and we respect and appreciate Russell’s commitment. I’m looking forward to hanging with him in The Netherlands. He’s assured us it’s the right time for him and he’s comfortable with the set and setting and with sharing his experience to the world.”

“I’m excited to facilitate Russell on his truffle journey. It will be fascinating to hear Russell share his experience with the world since every journey is unique,” said Jeff Hamburg, Red Light Holland Therapist and expert psychedelic facilitator. “I am confident this will be beneficial not only to Russell himself, but to others hearing and learning about the potential benefits of such an experience.”

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the Russell Peters ability to get to the Netherlands, the anticipated journey facilitated by Jeff Hamburg, the intimate live event featuring Russell Peters and the live-streaming of the event; the commencement and projected date regarding the Company’s ability to ensure the live event will happen on the Company’s social media accounts, the venue for the event; statements about the future of the live session with Russell Peters, Jeff Hamburg providing support, with respect to live journey; and expectations for other economic, business, and/or competitive factors.

October 8, 2021March 10, 2022

Red Light Holland Expands the iMicrodose Brand and Unveils New iMicrodose Products: Triniti, Uniti and Mindfuli

Toronto, Ontario–(Newsfile Corp. – October 8, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce they have unveiled new iMicrodose Products powered by Red Light Holland. The new iMicrodose magic truffles Triniti, Uniti and Mindfuli will be made available for sale (Business to Business) through Red Light Holland’s wholly owned subsidiary SR Wholesale (“SR Wholesale”) in the Netherlands and Business to Consumer through the company’s web site www.iMicrodose.nl by November, 2021.

iMicrodose Packs (Triniti, Uniti, OG, Mindfuli) powered by Red Light Holland

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/99024_7423771954803b17_001full.jpg

Triniti, Uniti and Mindfuli Magic Truffles join the original iMicrodose packs powered by Red Light Holland, which are currently in 25 smart shops plus available online in 3 other e-commerce sites, including www.iMicrodose.nl. Triniti, Uniti and Mindfuli will be produced and packaged in the Red Light Holland Truffle farm, in Horst, The Netherlands. The company is continuously growing three Truffle strains, Mexicana, Galindoi and Tampanensis which will be used for the new iMicrodose Product offerings.

“What’s really exciting is we believe we are the first company in the Netherlands to offer microdosing with 3 different varieties of Magic Truffles in one package, as Triniti powered by Red Light Holland will contain all three strains of Truffles – Galindoi, Mexicana and Tampanensis – grown in our farm. This gives the opportunity for consumers to try all three strains and to figure out which one may be best suited for them,” said Hans Derix, Red Light Holland’s President. “Living here in the Netherlands, and watching life open up has inspired us to not just grow Magic Truffles but as well to grow the iMicrodose brand. We are proud of the packaging and design of the new iMicrodose packs and we are elated to be able to have such a large distribution wholesale network – SR Wholesale – to really push this brand and expanded product line to our retail partners.”

“Our research shows there is increased interest in microdosing with natural Psilocybin world wide. The Netherlands is our first legal market and by increasing our product offerings and testing them with our consensual data gathering app www.iMicroapp.com and our telecounseling platform we can believe we can help regulatory bodies around the world realize the potential,” said Sarah Hashkes, Red Light Holland Chief Technology and Innovation Officer. “Each iMicrodose pack comes with a QR code making it easier for customers to sign up to the iMicro App and join our community. We aim to share this unique data in Q4 of 2021.”

“We continue to grow as a company and offering new products, which we produce, to the market is part of our strategy to increase profit margins. SR Wholesale will have a clear focus on selling the new iMicrodose packs which come directly from our farm in the Netherlands showing true vertical integration,” said Todd Shapiro, Chief Executive Officer and Director of the Company. “We have a clear plan to get Red Light Holland products into many more retail stores and we will continue to push for sales on our e-commerce online platform at www.iMicrodose.nl. We’re very proud to be providing responsible access now and we love that the iMicrodose line-up continues to expand giving end consumers the ability to try more products.”

iMicrodose packs Triniti, Uniti and Mindfuli powered by Red Light Holland will be made available at www.iMicrodose.nl and via SR Wholesale to retail shops in the Netherlands to adults 18+ by early November 2021.

About Red Light Holland

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the continuous growth of truffles in the Company’s farm in Horst, the Netherlands, the anticipated sales abilities, network, connections and the reach of SR Wholesale and the amount of retail shops products are currently in; the commencement and projected sales’ dates regarding the Company’s iMicrodose Products from SR Wholesale and/or the Company’s website www.iMicrodose.nl; statements about the future of the Company’s iMicrodose Products, the iMicro App, tele-counselling support, the collection of data, including with respect to the growth and future sales; and expectations for other economic, business, and/or competitive factors.

October 8, 2021March 10, 2022

Shrooms win the Seattle fight club: issue 18

Here’s what’s in store for you in today’s issue:

🍄 A trippy (family-friendly) vacay

🍄 Microdosing for pain management

🍄 Psychedelic beverages

🍄 The largest US city to decriminalize shrooms

🍄 And more.

You’ll want to stay till the end to learn how someone discovered their inner child with help from mischievous spirits!

(Did a good friend forward this to you? If so be sure to subscribe here)

Be sure to check out this week’s Daily Mushroom podcast:
Psychedelic medicines could hold a promise never seen before in mental healthcare

In this episode we have Dave Philips, a registered clinical counselor who has integrated psychedelic therapy into his practice. Dave talks about how he is training the next generation of psychedelic counselors and how he started in this extraordinary field.

A trippy (family-friendly) vacay

Patients in palliative care have higher rates of depression – could a psychedelic retreat change this?

Launched yesterday in Utah, “Psychedelic Palliative Care by Novamind” combines psychedelic-assisted therapy with workshops, multi-day immersive retreats, and group support at its recently-opened clinic.

“Due to psychedelic medicine’s generally low side effect burden and fast-acting nature, it shows promise for patients who are physically ill and might have limited life expectancies,” said Novamind’s Chief Scientific Officer.

Fight Club💥

Lobe Sciences (LOBE) is partnering with the the World Boxing Association (“WBA”) to help boxers manage brain injuries!

The organizations plan to launch a global registry to identify former and current boxers with mild traumatic brain injury (mTBI) and help them manage the side effects, which can often include PTSD. The WBA will also develop best practices for early diagnosis of mTBI that can be used immediately after fights for current boxers.

Injured boxers could potentially be treated with Lobe’s therapeutic regimen, which utilizes the combination of psilocybin and NAC (the pneumonia drug) mentioned in last week’s issue.

E. coli + shroom moonshine anyone?

A recent study suggests that it’s possible to produce a potent “psilocybin moonshine” using a fast and simple homebrew method that doesn’t involve growing mushrooms or sterilization.

Researchers inserted magic mushroom genes into E. coli bacteria, which was then added to bottles, submerged in a water tank that was aerated with an aquarium pump, and covered with aluminum foil to maintain a temperature of 37 °C.

In less than two days, 300 mg of psilocybin was produced per liter of water. The method even worked without sterilization, but produced only 100 mg/L, yet this deficit was counteracted by adding a form of penicillin.

Even boomers want to microdose

New market research shows a growing interest in psilocybin services!

Red Light Oregon, a 50/50 joint venture between Red Light Holland (TRUFF) and Halo Collective (HALO), conducted market research to help the Oregon Psilocybin Advisory Board (OPAB) and health officials make informed regulations.

Of 473 Oregonian adults surveyed, 86% showed in interest in microdosing, including 94% of Gen Z and 74% of Boomers. As a result, Red Light Oregon launched an advocacy program to educate the OPAB and health officials on the benefits of microdosing.

The survey also found that 37% of adults, mainly minorities, did not know what psilocybin is, so the company is launching a community outreach program to educate underserved populations on psilocybin’s therapeutic effects.

Turn the music up, it’s sad boi hour

Scientists confirmed what mushroom users have long known…

In a study conducted by a Copenhagen University researcher, psilocybin was found to increase the emotional response to music, whereas the control drug, ketanserin (a blood pressure medication), lessened the emotional response.

Participants listened to 10 minutes of classical music and were assessed on the Geneva Emotional Music Scale, which measures nine mental states: wonder, transcendence, tenderness, nostalgia, peacefulness, power, joyful activation, tension, and sadness. Those on psilocybin showed a 60% increase in emotions.

“What we need to do now is optimize this approach probably through individualizing and personalizing music tracks in therapy,” says Professor David Nutt of Imperial College London.

New ways to consume drugs 🎉

Will shroom edibles and drinks be the next big thing in Cali?

Cannabis Global Inc. (CBGL) is developing methods to infuse psilocybin and psilocin, as well as other compounds found in psychedelic mushrooms, into foods and beverages.

The LA-based company has initiated research into infusion methods to improve bioavailability of the compounds and to mask the bitter flavour of the mushrooms. It has already filed 9 patent applications for its cannabinoid infusion technologies, which it hopes to leverage for this new research program.

With the state of California on track to have a psilocybin legalization measure on the 2022 ballot, the program could potentially serve a large marketplace in the near future.

Managing pain across the globe

Could microdosing + this new technology reduce pain in cancer patients?

MindBio Therapeutics is developing a technology platform to integrate with psychedelic therapy to prevent the mental health of cancer patients from deteriorating. By utilizing wearable devices, the platform is designed to help with pain management to prevent depression, existential distress, and anxiety.

MindBio Therapeutics will use the mindfulness app in an upcoming Phase 2 microdosing trial, which is funded by the New Zealand government, to see if it provides additional benefits to late-stage cancer patients compared to microdosing alone.

The company aims to commercialize the application globally and believes the tech has potential to receive government funding in Europe.

More psilocybin please!

This new extraction method could yield more psilocybin from a single mushroom than previously possible.

Natural psilocybin extraction can have low and unstable yields, which is why many companies opt for synthetic versions. When mushrooms are dehydrated, the total psilocybin/psilocin content extracted is three times lower than the total amount believed to be in the mushroom.

Optimi Health (OPTI) developed an extraction technique that not only increases the yield of natural psilocybin, but also protects the compounds from degeneration while reducing the cost of the final drug. On Tuesday, the company announced that it filed a provisional patent application to protect the process.

Seattle becomes the largest US city to decriminalize psychedelics

With a unanimous vote, a new legislation was passed to decriminalize the possession, cultivation, and sharing of psychedelic mushrooms, ayahuasca, ibogaine and non-peyote-derived mescaline.

Peyote was intentionally excluded from the measure, as it’s in danger of extinction due to the increase in illegal harvesting. In fact, Santa Cruz recently removed peyote and other mescaline-containing cacti from the city’s decriminalization policy after pushback from Indigenous groups that consider the entheogens to be sacred.

Psychedelic reform coming this year!

It’s time for the federal government to catch up with the rest of America.

At a psychedelics policy symposium organized by Harvard’s Project on Psychedelics Law and Regulation (POPLAR), Rep. Earl Blumenauer (D-OR) said he plans to bring drug reform to the Capitol this year!

“I promise you I will do my part—not only assisting in the evolution of the Oregon [psilocybin] program, but I plan on bringing this movement to Capitol Hill this year in the same way we developed the foundation for the support of our cannabis work,” he vowed.

This is why Gen Z should be in charge…

Some of the youngest state legislators in the US want to decriminalize all drugs.

Tony Labranche, a 19-year-old Rep. of New Hampshire, is pushing to establish a regulated cannabis sales system and decriminalize the possession of magic mushrooms, as well as all other controlled substances. The reform proposals are bold for a GOP-controlled state, but they’re sparking more dialogue about the need to end the war on drugs.

Back in February, a 20-year-old lawmaker filed a bill to broadly decriminalize drug possession in Kansas, noting that drug use should be treated as a mental health problem rather than a criminal one.

Canada is following suit, with the city of Toronto preparing to ask Health Canada to decriminalize all drugs, similar to Vancouver’s request in May.

Progress down under

Australia’s Therapeutic Goods Administration (TGA) may reschedule psilocybin and MDMA after recognizing their therapeutic potential.

The substances are currently classified as Schedule 9, or “prohibited substances”, creating a barriers for conducting clinical research. The TGA is considering changing the classification to Schedule 8, or “controlled substances” (the same as THC) to allow controlled use in clinical settings.

The verdict will be announced in the first week of December after an advisory committee meeting!

Industry Quick Hits

Oct 1 – Psychedelic biotech startup Psylo raises $1.1m to treat mental health issues with psilocybin Read more…

Oct 4 – Incannex Healthcare (IHL) raises close to $18m, including $8m from chief medical officer Read more…

Oct 4 – Delix Therapeutics Named One of Fierce Biotech’s “Fierce 15” Companies of 2021 Read more…

Oct 5 – Mydecine (MYCO) To Supply MYCO-001 for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson Read more…

Oct 5 – MindMed (MNMD) Announces Strategic Research Collaboration with Sphere Health Read more…

Oct 6 – Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio Read more…

Oct 6 – Creso Pharma’s (CPH) psychedelics subsidiary proceeds to stability testing ahead of clinical trial Read more…

Oct 7 – Cybin (CYBN) Announces Milestone Achievements of its Subsidiary Adelia Therapeutics Read more…

Oct 7 – Tryp Therapeutics (TRYP) Announces Collaboration With Researchers At The University Of Wisconsin-Madison Read more…

Oct 7 – PsyBio Therapeutics (PSYB) Successfully Demonstrates Commercial Scale Manufacturing Feasibility Read more…

Oct 7 – MYND Life Sciences (MYND) Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – MYND Diagnostics Ltd. Read more…

Oct 7 – HAVN LIFE (HAVN) Files Final Base Shelf Prospectus Read more…

Video of the Week

Playing with mischievous spirits

This Reddit user found their inner child with help from some cheeky entities.

“On my first trip, I was taken to my afterlife and was touched by the unconditional universal love. It was so beautiful and I cry everytime I try to tell anyone about it because it felt so powerful. I’m crying now lol. I felt like I was in the presence of God. I was shown my Heaven and was told that there is nothing to fear about dying. I felt so much love from God towards me, it was overwhelming but very healing. It was like the love I feel for my children…. total acceptance, no judgement, unconditional positive regard.

On the next few trips I met a variety of more playful spirits who would ‘play’ with me like children would. Some were quite cheeky and mischievous. I called them my ragtag band of misfits. They really like to portray themselves to me as pirates. They helped to bring out the child in me and my sense of fun which I must admit I had burried deep inside due to life circumstances. My partner, who is my usual trip sitter, always hoped I would meet them because he liked seeing my cheeky side come out. My pirate friends liked him too and often made me say funny things to him, but they were always respectful towards him. Eventually, they stopped coming to me, to make way for higher beings who had other lessons to teach me. I miss those rascals and I hope to see them again some day.”

Playlist of the Week

October 5, 2021March 10, 2022

Red Light Holland Expands Product Offerings and Rebrands Maka Truffles as a Responsible Use Psychedelic

Toronto, Ontario–(Newsfile Corp. – October 5, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company”), an Ontario-based corporation engaged in the production, growth, and sale of a premium brand of magic truffles, is pleased to announce they have expanded their product offerings with Maka magic truffles powered by Red Light Holland. The newly branded Maka magic truffles include 6 different varieties, Hollandia, Makanaut, Muskoka, Mexicana, Atlantis, and Double Vision and they all come in unique, clever and eye-catching packaging. Maka Magic Truffles will be made available for sale (Business to Business) through Red Light Holland’s wholly owned subsidiary SR Wholesale (“SR Wholesale”) in the Netherlands by November. As well, Business to Consumer through their own web site www.WorldofMaka.com powered by Red Light Holland by mid November 2021.

Maka Hollandia

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/98625_d7fdd9d0e4cf9a9f_001full.jpg

Maka Mexicana

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/98625_d7fdd9d0e4cf9a9f_002full.jpg

Maka Muskoka

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/98625_d7fdd9d0e4cf9a9f_003full.jpg

Red Light Holland continues to lead in responsible use advocacy. Through the Maka website customers will be able to participate in bi-monthly online preparation and integration sessions with Red Light Holland’s therapist and psychedelic journey expert Jeff Hamburg. The Maka Magic Truffles will come together with a creative booklet focused on optimal set and setting for psychedelic trips.

Maka Atlantis

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/98625_d7fdd9d0e4cf9a9f_004full.jpg

Makanaut

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/98625_d7fdd9d0e4cf9a9f_005full.jpg

Maka Double Vision

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/98625_d7fdd9d0e4cf9a9f_006full.jpg

“By rebranding Maka, which means earth, we are staying aligned to the vision of responsible use. We are providing Maka costumers with free access to expert knowledge while building a community around growth and connection. We believe we need more connection on and to Earth, and we are proud of this initiative,” said Todd Shapiro, Chief Executive Officer and Director of the Company. “The new Maka product offerings, produced by the Red Light Holland Truffle Farm which will be distributed by our wholly owned subsidiary plus our e-commerce websites show true vertical integration and hence, create increased profit margins. We believe the Smart Shops will love this rebrand, of an already familiar product, so we are excited to get them on shelves too!”

“The use of psychedelics can be a powerful, life-changing experience. Preparation, a safe set and setting, a healthy mindset and understanding how to integrate the experience are all an integral part of the psychedelic journey and we at Maka are here to support those who go on this journey,” said Jeff Hamburg, Red Light Holland therapist and psychedelic journey expert.

Maka Magic Truffles powered by Red Light Holland will be made available at www.WorldOfMaka.com, for sale only in the Netherlands to adults 18+ by mid-November 2021.

About Red Light Holland

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

Forward-Looking Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or their respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the anticipated sales abilities, network, connections and the reach of SR Wholesale; the commencement and projected sales’ dates regarding the Company’s Maka Products from SR Wholesale and/or the Company’s website www.WorldOfMaka.com; statements about the future of the Company’s Maka Products, including with respect to the future sales; and expectations for other economic, business, and/or competitive factors.

September 29, 2021March 10, 2022

Even boomers want to microdose

Red Light Oregon Market Research Shows High Interest in Psilocybin Services With 86% of Adults Interested in Microdosing

New market research shows a growing interest in psilocybin services!

Of 473 Oregonian adults surveyed, 86% showed in interest in microdosing, including 94% of Gen Z and 74% of Boomers. 84% said they were interested in the mental health effects of psilocybin, with 49% interested in paying for psilocybin services. As a result, Red Light Oregon launched an advocacy program to educate the OPAB and health officials on the benefits of microdosing.

PDF of article

September 29, 2021March 10, 2022

Red Light Holland: Initial Results From Red Light Oregon Market Research in Oregon Show 86% of Adults Interested in Psilocybin Services are Interested in Microdosing

Toronto, Ontario–(Newsfile Corp. – September 29, 2021) – Red Light Oregon, Inc. (“Red Light Oregon“) a 50/50 joint venture of Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF) (FSE: A9K) (“Halo Collective“) and Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF), (“Red Light Holland“), is pleased to announce preliminary findings from a statistically significant and representative market study of Oregon adults. The market research study (the “Market Research Study“), aimed to gather insights on the likely beneficiaries of Measure 109 and the legalization of psilocybin services by the Oregon Health Authority (“Psilocybin Services“) for adults in Oregon and help support the Oregon Psilocybin Advisory Board (OPAB) and health officials in making data-informed regulations.

Some Initial data from the Market Research Study has uncovered:

● 86% of adults interested in Psilocybin Services are interested in microdosing.
● 49% of those interested in Psilocybin Services are interested in services such as increasing creativity (35%), exploring their mind (29%) and exploring spirituality (29%).
● Oregonians who are not interested in Psilocybin Services because they don’t want to pay for them list their largest concern is supporting Big Pharma.
● 84% of those interested in Psilocybin Services are interested in services to help with their mental health.
● While nearly half of all adults (49%) are interested in paying for Psilocybin Services, 37% of Adults in Oregon do not know what psilocybin is. In addition, women, people who have not completed a college degree, and Asian minorities in Oregon are less likely to know what psilocybin is.
● On average, people would like to pay around $100 USD for a psilocybin therapy session and approximately $50 USD for a microdosing session. However, there is a significant difference between those in lower-income brackets vs. higher income brackets ($93 USD vs. $223 USD, respectively).
● There is a trend showing younger adults are more interested in Microdosing than Boomers (94% Gen Z, 74% Boomers), although it did not reach statistical significance in the sample size.

Based on this data, Red Light Oregon has:

● Launched a community outreach program to educate the public and health care providers about the latest scientific research around psilocybin and the opportunities of Measure 109. Red Light Oregon will be focusing on reaching out to underserved populations, as seen in the data, which have not had the privilege to be exposed to the potential benefits of psilocybin. The program will utilize Wisdom, a VR app that explains the effects of psilocybin on the brain. You can register to receive more information on: https://redlightoregon.com/.
● Launched an advocacy program to educate the Oregon Psilocybin Advisory Board and Oregon health officials around the potential benefits of microdosing and the ability to increase the equity of Measure 109 with regulation specifically addressing microdosing, which is a lower-priced service. Red Light Oregon aims to work with Oregon authorities utilizing Red Light Oregon’s legal advisor to assist in bridging the gap between regulations and what the people in Oregon want.

Below are some of the answers from the 49% of adults in the sample from Oregon interested in paying for Psilocybin Services.

Figure 1

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/97989_b4d06c49c41a68f4_001full.jpg

Figure 2

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/97989_b4d06c49c41a68f4_002full.jpg

Figure 3

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/97989_b4d06c49c41a68f4_003full.jpg

Figure 4

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/97989_b4d06c49c41a68f4_004full.jpg

“The data Red Light Oregon has received, so far, from Oregon is showing the immediate need people have for psychedelic services to help with mental health. The data also shows many of them are interested in microdosing,” said Todd Shapiro, CEO, and Director of Red Light Holland. “Measure 109 is focused on equity, and equity starts with education, which is why we have launched our community outreach program. Oregonians have also shown us their genuine concern around supporting Big Pharma and Red Light Oregon is committed to being the people’s company starting by listening to what the people want while advocating for legal access through education, information, and responsible use.”

“With 51% of adults interested in Psilocybin Services and 88% of those respondents being interested in microdosing, we believe there is a huge opportunity for a company with our shared expertise to provide the people of Oregon with the best services,” added Katie Field, Co-President of Red Light Oregon and President and Executive Director at Halo Collective.

“Psilocybin has meaningful potential to help people grow and heal, and it’s everyone’s responsibility to make sure the benefits from this natural substance are available to everyone even if they don’t make six figures. We are impressed with the OPAB’s emphasis on equity and hope this data will help them come up with recommendations that will ensure this goal. For Measure 109 to be equitable, it should also take into account the wants of the younger generation and make sure that group sessions and microdosing are clearly defined in the regulation to increase accessibility to lower-priced Psilocybin Services,” said Sarah Hashkes, Co-president of Red Light Oregon and Chief Technology and Innovation Officer of Red Light Holland.

Further data from the survey continues to be analyzed. An official report is estimated to be released to the public, the OPAB and health officials in mid-October.

Measure 109 will make Psilocybin Services available to 21 years and older in Oregon who think they can benefit from them without a need for medical diagnosis. The service must include a required prep-session, psilocybin session in a licensed facility supervised by a licensed facilitator and a possibility of an integration session. On December 31, 2022, the Oregon Health Authority will prescribe forms and regulations necessary for the exact implementation.

About Red Light Oregon

About Halo Collective Inc.

For further information regarding Halo Collective, see Halo Collective’s disclosure documents on SEDAR at www.sedar.com.

Connect with Halo Collective: Email | Website | LinkedIn | Twitter | Instagram

About Red Light Holland Corp.

For additional information:

Todd Shapiro
Chief Executive Officer, Chairman, and Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

Forward-Looking Statements

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: statements regarding Red Light Oregon’s community outreach and advocacy programs; the intended outcomes and effects of Measure 109; statements regarding the implementation of Measure 109 by the Oregon Health Authority; Halo Collective’s expansion and vertical integration plans, including the buildout of Ukiah Ventures; Halo Collective’s intended spin-off of the assets, intellectual property, and patent applications of Accudab into its subsidiary Halo Tek Inc.; and Halo Collective’s plans to reorganize its non-U.S. operations into a newly formed entity called Akanda.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of Red Light Holland to continue as a going concern; the risks associated with the psychedelics industry in general; increased competition in the recreational and medical psilocybin markets; the potential future unviability of the psychedelics industry; public opinion and perception of the psychedelics industry; incorrect assessment of the value and potential benefits of expansion plans and various transactions; risks associated with potential governmental and/or regulatory action with respect to the psychedelics industry; changes in general economic, business and political conditions, including changes in the financial and stock markets; and risks related to infectious diseases, including the impacts of the COVID-19 pandemic.

September 14, 2021March 10, 2022

Red Light Holland Engages Marketing Veteran and Brand Strategist, Ridley Doolittle, as Advisor to Advisory Board

Toronto, Ontario–(Newsfile Corp. – September 14, 2021) – Red Light Holland Corp. (CSE: TRIP) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles is pleased to announce that it has engaged Ridley Doolittle, to serve as an advisor (“Advisor“) to its Advisory Board. Mr. Doolittle brings over 15 years of high-quality strategic marketing and rate of sale commercial excellence in both the consumer packaged goods (“CPGs“), ready-to-drink (“RTD“) and start-up spaces. Mr. Doolittle most recently exited Bacardi as a Senior Brand innovation officer working across the North American landscape, to focus on consulting with companies who are looking to grow via marketing and innovative products offerings with the clear goal of resulting in global exposure and increased sales. Ridley Doolittle joins a strong team of advisors, including the Chairman of the Advisory Board Bruce Linton, to provide strategic advice and support to Chief Executive Officer Todd Shapiro, with respect to marketing and product innovation due to his background, expertise, vision and proven success of brand growth and product creation with both General Mills and Bacardi.

“Ridley is perfect for the role of immediately helping with Happy Caps home grow kits, while also assisting us in the Netherlands and across Europe with our iMicrodose products as well,” said CEO Todd Shapiro. “Ridley is someone I’ve personally worked with in the past when he was with Bacardi. Our working relationship was always very professional and respectful and his background and experience, especially with Bacardi and the ready-to-drink segment speaks for itself. I believe he’ll instantly be a tremendous asset to the Red Light Holland team as he immediately helps contribute to exploring future product offerings, marketing exposure and reach focused on increasing sales of our Red Light Holland consumer packaged goods. We’re pleased to have someone with his marketing know-how and work ethic,” said Todd Shapiro, CEO of Red Light Holland

“I am honoured to join this incredible team,” added Ridley Doolittle. “When I look across the wider North American consumer landscape today, it’s clear to me that the next generation of consumers are behaving completely different than any generation prior to them – in terms of their social activities, enjoyment choices and their stance on health and wellness.”

Mr. Doolittle goes on to say, “The opportunity to pull from my experience as a consumer- focused brand leader in the CPG and Premium Alcoholic Beverage category, and transfer this into the psychedelic and functional mushroom growth sectors with this incredible team, is hugely exciting.”

In consideration for his services as Advisor, and subject to all applicable laws (including the rules and policies of the Canadian Securities Exchange) (“Applicable Laws“) and the approval of the board of directors of the Company (the “Board“), the Company intends to grant to Mr. Doolittle up to 200,000 incentive stock options (the “Options” and each individually, the “Option“). 100,000 Options will vest upon certain milestones being achieved with respect to sale of Happy Caps home grow kits. Each Option will entitle the holder thereof to acquire one common share in the capital of Company for a period of three years from the date of issuance, at an exercise price of $0.25. The Options shall be subject to Applicable Laws and the terms and conditions of the Stock Option Plan of the Company, and will be subject to a hold period of four months plus one day from the date of issuance.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer, Chairman, and Director
Tel: 647-204-7129
Email: todd@redlighttruffles.com
Website: https://redlighttruffles.com/

Forward-Looking Statements

Neither the Canadian Securities Exchange (the “CSE“) nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release contains “forward-looking information” within the meaning of applicable securities laws, which may include, but is not limited to, statements with respect to the future benefits and or outcomes related to the Company’s engagement of Mr. Doolittle. Although the Company believes in light of the experience of its directors and officers, current conditions and expected future developments and other factors that have been considered appropriate and that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Any such forward-looking statements may be identified by words such as “expects”, “anticipates”, “believes”, “projects”, “plans” and similar expressions. Readers are cautioned not to place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, the risk that the Company’s engagement of the Advisory may not be as beneficial in the ways set out in this Press Release. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assume no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Be sure to check out this week’s Daily Mushroom podcast: Psychedelic medicines could hold a promise never seen before in mental healthcare

Industry Quick Hits

Oct 1 – Psychedelic biotech startup Psylo raises $1.1m to treat mental health issues with psilocybin Read more…

Oct 4 – Delix Therapeutics Named One of Fierce Biotech’s “Fierce 15” Companies of 2021 Read more…

Oct 5 – Mydecine (MYCO) To Supply MYCO-001 for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson Read more…

Oct 6 – Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio Read more…

Oct 6 – Creso Pharma’s (CPH) psychedelics subsidiary proceeds to stability testing ahead of clinical trial Read more…

Oct 7 – Cybin (CYBN) Announces Milestone Achievements of its Subsidiary Adelia Therapeutics Read more…

Oct 7 – Tryp Therapeutics (TRYP) Announces Collaboration With Researchers At The University Of Wisconsin-Madison Read more…

Oct 7 – PsyBio Therapeutics (PSYB) Successfully Demonstrates Commercial Scale Manufacturing Feasibility Read more…

Oct 7 – MYND Life Sciences (MYND) Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – MYND Diagnostics Ltd. Read more…

Oct 7 – HAVN LIFE (HAVN) Files Final Base Shelf Prospectus Read more…

Video of the Week

Playlist of the Week

Be sure to check out this week’s Daily Mushroom podcast:
Psychedelic medicines could hold a promise never seen before in mental healthcare